Gbg Is A Privately-Owned, Matrixed, Diagnostics And Drug Development / Cro Company
Current08'22 - PresentGBG - Director of Oncoveda Cancer Research InstituteDeveloping small molecule discovery programs that exploit viral detection mechanisms.
Please complete the CAPTCHA to continue
@elsevier.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Grant Gallagher is listed as Director - Oncoveda Cancer Research Institute, Genesis Biotechnology Group (GBG) at Genesis Biotechnology Group, based in Trenton, New Jersey, United States. AeroLeads shows a work email signal at elsevier.com and a matched LinkedIn profile for Grant Gallagher.
Grant Gallagher previously worked as GBG is a privately-owned, matrixed, diagnostics and drug development / CRO company at Genesis Biotechnology Group and Adjunct Professor: Department of Molecular Biology at Rowan University. Grant Gallagher holds B.Sc., (Hons); Ph.D., Biochemistry And Immunology. from University Of Strathclyde.
This section adds company-level context without repeating Grant Gallagher's masked contact details.
AeroLeads found 1 current-domain work email signal for Grant Gallagher. Compare company email patterns before reaching out.
CAREER SUMMARY:In both academia and biotechnology, I have researched the role of human immune cells in health and disease. I am successful and productive within priority-dynamic, matrixed environments. I have led research into: * Cancer immunobiology and small-molecule discovery; * Compound screening against human immune targets; * Discovery and biology of IFNs-Lambda, and IL-19; * Role of cytokine genetics as prognostic biomarkers; * Use of one-time-only patient material in clinical studies; * Bringing a candidate molecule towards Phase-1.This work has yielded 27 issued US Patents, 86 peer-reviewed publications, graduated 26 research students and garnered over $5M in grant funding.My Research Gate profile is here: http://www.researchgate.net/profile/Grant_Gallagher
Listed skills include Biochemistry, Lifesciences, Genetics, Biotechnology, and 46 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Hamilton, NJ, US
08'22 - PresentGBG - Director of Oncoveda Cancer Research InstituteDeveloping small molecule discovery programs that exploit viral detection mechanisms.
Bethesda, MD, US
NIH - Immunology and Inflammation, Basic Research & SBIR/STTR, 60 panels, 2006 - 2016.International - Hong Kong, Portugal, Singapore, United Kingdom, 2004 - 2019.
Glasgow, Glasgow, GB
Quick answers generated from the profile data available on this page.
Grant Gallagher works for Genesis Biotechnology Group.
Grant Gallagher is listed as Director - Oncoveda Cancer Research Institute, Genesis Biotechnology Group (GBG) at Genesis Biotechnology Group.
AeroLeads has found 1 work email signal at @elsevier.com for Grant Gallagher at Genesis Biotechnology Group.
Grant Gallagher is based in Trenton, New Jersey, United States while working with Genesis Biotechnology Group.
Grant Gallagher has worked for Genesis Biotechnology Group, Rowan University, Us National Institutes Of Health, And International, Nature Publishing Group, and University Of Medicine And Dentistry Of New Jersey.
You can use AeroLeads to view verified contact signals for Grant Gallagher at Genesis Biotechnology Group, including work email, phone, and LinkedIn data when available.
Grant Gallagher holds B.Sc., (Hons); Ph.D., Biochemistry And Immunology. from University Of Strathclyde.
Grant Gallagher is listed with skills including Biochemistry, Lifesciences, Genetics, Biotechnology, Immunology, Cell, Cancer, and Infectious Diseases.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts